Related Experiment Video
Updated: Oct 5, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
WITHDRAWN: Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Controlled Trial
Michael W A Chu1, Marc Ruel2, Allen Graeve3
1London Health Sciences Centre, Western University, London, ON, Canada.
This study has been withdrawn. The publisher apologizes for any inconvenience. Further information regarding article withdrawal policies is available.
Area of Science:
- Not applicable as the article has been withdrawn.
Background:
- Not applicable as the article has been withdrawn.
Purpose of the Study:
- Not applicable as the article has been withdrawn.
Main Methods:
- Not applicable as the article has been withdrawn.
Main Results:
- Not applicable as the article has been withdrawn.
Conclusions:
- Not applicable as the article has been withdrawn.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care

